Conspire.to
research
Translate this page

Research

Virucidal efficacy of hypochlorous acid water for aqueous phase and atomization against SARS-CoV-2

iwaponline.com · added Jun 2024

Summary

In a lab study, ionless hypochlorous acid water inactivated SARS-CoV-2 (Wuhan and Delta strains) in solution within 20 seconds, and hours of HOCl mist reduced virus on plastic plates; organic matter weakened the effect.

Key points

  • Tested ionless HOCl water against SARS-CoV-2, in suspension and by spraying.
  • In the suspension test, 20 seconds of HOCl treatment significantly inactivated both the Wuhan and Delta strains.
  • Organic matter in the solution reduced the effect.
  • Atomizing HOCl for several hours significantly reduced virus attached to plastic plates.
  • A lab study of virus in solution and on plastic plates; it did not test breathing the mist or any effect on people.

Issue Cover (opens in a new tab)

Abstract

Listen (opens in a new tab)

View large (opens in a new tab)Download slide (opens in a new tab)

Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged at the end of 2019. SARS-CoV-2 can be transmitted through droplets, aerosols, and fomites. Disinfectants such as alcohol, quaternary ammonium salts, and chlorine-releasing agents, including hypochlorous acid, are used to prevent the spread of SARS-CoV-2 infection. In the present study, we investigated the efficacy of ionless hypochlorous acid water (HOCl) in suspension and by spraying to inactivate SARS-CoV-2. The virucidal efficacy of HOCl solution in tests against SARS-CoV-2 was evaluated as 50% tissue culture infectious dose. Although the presence of organic compounds influenced the virucidal efficacy, HOCl treatment for 20 s was significantly effective to inactivate Wuhan and Delta strains in the suspension test. HOCl atomization for several hours significantly reduced the SARS-CoV-2 attached to plastic plates. These results indicate that HOCl solution with elimination containing NaCl and other ions may have high virucidal efficacy against SARS-CoV-2. This study provides important information about the virucidal efficacy and use of HOCl solution.

HIGHLIGHTS

Listen (opens in a new tab)

  • The virucidal effect of ionless hypochlorous acid water (HOCl) was unaffected by SARS-CoV-2 variants.
  • The anti-SARS-CoV-2 effect of HOCl was attenuated by organic compounds in the virus solution.
  • The anti-SARS-CoV-2 effect of HOCl was confirmed by HOCl atomization.
  • Use of HOCl atomization against anti-SARS-CoV-2 effect can be expected to reduce the burden of cleaning in hospital rooms, daycare centers, schools, etc. atomization, coronavirus disease 2019 (COVID-19), hypochlorous acid water (HOCl), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), suspension test

ABBREVIATIONS

Listen (opens in a new tab)

ACCavailable chlorine concentrationCOVID-19coronavirus disease 2019HOClhypochlorous acid waterMPOmyeloperoxidaseROSreactive oxygen speciesSARS-CoV-2severe acute respiratory syndrome coronavirus 2TCID5050% tissue culture infectious dose

INTRODUCTION

Listen (opens in a new tab)

The new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus of coronavirus disease 2019 (COVID-19), which emerged at the end of 2019 and has since spread rapidly worldwide (Zhu et al. 2020). The clinical symptoms of COVID-19 vary widely from asymptomatic to severe, and it can be fatal (Chen et al. 2020; Guan et al. 2020). As of 28 August 2023, the World Health Organization (WHO) confirmed 770 million cases and >6.9 million deaths (WHO 2023).

SARS-CoV-2 is an enveloped positive-sense single-stranded RNA virus, which can spread through asymptomatic and symptomatic individuals through ejected respiratory droplets and aerosols when breathing, coughing, sneezing, and speaking under insufficient ventilation (Hu et al. 2021; Leung 2021). The virus can survive from a few hours to several days on various material surfaces, such as glass, plastic, natural rubber, and metal (Riddell et al. 2020; van Doremalen et al. 2020; Hirose et al. 2021; Wiktorczyk-Kapischke et al. 2021). Therefore, the droplet infection and fomite transmission are feasible routes of infection. Consequently, to prevent human-to-human viral transmission, it is important to inactivate SARS-CoV-2 in the form of released droplets or on the surface of fomites. In addition, handwashing and hand disinfection are also important to prevent SARS-CoV-2 infection.

For this purpose, the use of chemical disinfectants and sanitizers can reduce the high risk of pathogen transmission. We have explored or developed various disinfectants and sanitizers to prevent infectious diseases. The main components used in disinfectants and sanitizers contain alcohol, quaternary ammonium salts, and amphoteric surfactants (McDonnell & Russell 1999; Tischer et al. 2012; Gerba 2015; Tsujimura et al. 2015; Falk 2019; Xiao et al. 2022). At the beginning of the COVID-19 pandemic, the demand for alcohol disinfectants increased. Therefore, alternative disinfectants were evaluated in Japan. Ionless hypochlorous acid water (HOCl) is one of the several reactive oxygen species produced by phagocytes, such as macrophages and neutrophils, playing a key role in disinfection of bacteria, fungi, protozoa, and viruses (Aratani 2018). HOCl is a strong oxidizing agent with antipathogen efficacy. HOCl has rapid and broad-spectrum antimicrobial efficacy against clinically relevant microorganisms in vitro and in vivo (Wang et al. 2007). HOCl was reportedly superior to hypochlorite or hydrogen peroxide in terms of therapeutic index, which is an indicator of the safety margin of a disinfectant (Wang et al. 2007). HOCl can inactivate Gram-negative and positive bacteria, fungi, and viruses (WHO 2021). HOCl exhibits high virucidal efficacy by interacting with viral structural proteins (capsid or surface compound), lipid envelope, and DNA/RNA (Block & Rowan 2020; Hawkins & Davies 2021; Qiao et al. 2022). HOCl can react better with thiol-containing compounds, such as cysteine, methionine, and glutathione, than other cellular components and therefore induces protein unfolding and aggregation (Gray et al. 2013; da Cruz Nizer et al. 2020). Hawkins & Davies (2002) reported that HOCl-induced DNA damage. HOCl reacts with unsaturated fatty acids and cholesterol and induces a change in membrane properties (Spickett et al. 2000; da Cruz Nizer et al. 2020). Previous studies have reported the viricidal efficacy of HOCl solution against influenza virus, herpes simplex virus, human immunodeficiency virus 1, and coronavirus in the aqueous phase (Tachikawa et al. 1999; Miyaoka et al. 2021). According to Hatanaka et al. (2022) and Takeda et al. (2021), HOCl solution containing 28 and 51–56 ppm of chlorine concentration is efficient against SARS-CoV-2. A study reported that >35 ppm of HOCl is efficient against SARS-CoV-2 infection (NITE: National Institute of Technology and Evaluation 2022). In the study, each experimental condition by five facilities was different, for example, the producing method of HOCl solution (electrolyzed or not electrolyzed), the concentration of fetal bovine serum (FBS; 1–5%) in the virus solution, and reaction rates (1:9 or 1:19) with HOCl and virus solution.

Atomization with HOCl reduces bacteria on surfaces in vitro and in the hospital room (Hakim et al. 2016; Miyazaki et al. 2022). The virucidal efficacy of HOCl atomization was reported against norovirus, avian influenza virus, and SARS-CoV-2 on surfaces (Park et al. 2007; Hakim et al. 2015; Urushidani et al. 2022). Details of the appropriate use of HOCl against SARS-CoV-2 in the aqueous phase and under atomization are unclear.

In the present study, we investigated whether HOCl treatment would influence the infectivity of SARS-CoV-2 to susceptible cells in the presence of the different concentrations of organic compounds and variants. We also explored whether HOCl atomization would provide effective disinfection to prevent SARS-CoV-2 infection.

MATERIALS AND METHODS

Cell culture

Listen (opens in a new tab)

VeroE6 cells expressing the transmembrane serine protease TMPRSS2 (VeroE6/TMPRSS2: JCRB1819) were purchased from the National Institutes of Biomedical Innovation, Health and Nutrition (JCRB Cell Bank, Osaka, Japan). VeroE6/TMPRSS2 cells were cultured in Dulbecco's modified Eagle's medium (D-MEM) GlutaMAX (Thermo Fisher Scientific, Tokyo, Japan) containing 5% heat-inactivated FBS (Vitromex, Vilshofen, Germany), 100 units/mL penicillin, and 100 mg/mL streptomycin (Nacalai Tesque, Inc., Kyoto, Japan), and 1 mg/mL G-418 solution (Roche Diagnostics GmbH, Mannheim, Germany) under biosafety level 2.

Virus

Listen (opens in a new tab)

The Pango lineage A virus strain that was prevalent in the early stages of the COVID-19 pandemic (JPN/TY/WK-521) was provided by the National Institute of Infectious Diseases. To compare more pathogenic and transmissible variants of concern with Pango lineage A virus, the Pango lineage B.1.617.2 virus strain (KUH355) was isolated clinically and provided by the Kitasato University Hospital. Both viruses were used to infect VeroE6/TMPRSS2 cells for virus expansion, and virus-infected cells were cultured in D-MEM containing 2% FBS. After 48 h of incubation, each virus-infected cell culture supernatant was collected and centrifuged at 3,000 rpm for 10 min at room temperature (23 °C) to eliminate cells and debris. Culture supernatants were divided and stocked at −80 °C until use. All viruses were treated in the biological safety cabinet class II type A2 (LAL-1500XPA2 + : Oriental Giken Inc., Tokyo, Japan) of biosafety level 3 (BSL3).

Reagents

Listen (opens in a new tab)

HOCl was provided by NIPRO Corporation (Osaka, Japan). HOCl was produced by the electrolysis of the saturated sodium chloride (NaCl) solution. The products were purified by reverse osmosis filtration to remove ions, such as Na+. The conductivity and pH of 500 ppm HOCl used in this study were 280.1 mS/cm and 6.24, respectively.

Suspension test

Listen (opens in a new tab)

The JPN/TY/WK-521 (2 × 107 pfu/mL) and KUH355 (1.5 × 107 pfu/mL) strains were mixed with 1–200 ppm of HOCl or water for injection (Otuska Pharmaceutical Co., Ltd, Tokyo, Japan) at a ratio of 1:9 and 1:99 for 20 s and 5 min, respectively. Three viral solutions were treated with the same HOCl concentration or water for injection. After treatment, the reaction was stopped by adding 10% sodium thiosulfate (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan) to the virus solution and HOCl mixture. Ten-fold serial dilutions of these solutions were then prepared using D-MEM. Each diluted mixture was then added to VeroE6/TMPRSS2 cells. After 3 days of incubation, culture supernatants were eliminated. Then, VeroE6/TMPRSS2 cells were fixed with the cold methanol (Nacalai Tesque) and stained with the 0.5% methylene blue (FUJIFILM Wako Pure Chemical Corporation) solution for calculation of the tissue culture infectious dose 50 (TCID50) using the Behrens–Karber method (Behrens & Karber 1953). Live cells were stained blue and macroscopically observed, whereas dead cells from SARS-CoV-2 infection were not stained:

The average value of TCID50 was used as the viral infectivity. All experiments were performed in the biological safety cabinet of BSL3.

Spray test

Listen (opens in a new tab)

The test chamber used for the spray tests was placed into the biological safety cabinet in BSL3. KUH355 (1.5 × 107 pfu/mL) virus solutions diluted 10- and 100-fold with double distilled water (ddw) were placed in plastic plates and placed on a wet towel in the test chamber (Figure 3). 30–500 ppm and 10–300 ppm of HOCl or distilled water were sprayed for 5 h using two ultrasonic atomizers. Each of the three plastic plates was treated with HOCl or distilled water at the same time. Plastic plates were collected at 1, 3, and 5 h, and 0.95 mL of recovery liquid (D-MEM) was added to the plastic plates, and the virus was suspended. Ten-fold serial dilutions of the virus solutions were prepared using D-MEM. Each diluted mixture was added into VeroE6/TMPRSS2 cells. After 3 days of incubation, the culture supernatants were eliminated. Then, VeroE6/TMPRSS2 cells were fixed with cold methanol and stained with 0.5% of methylene blue solution for the calculation of TCID50 by the Behrens–Karber method. All experiments were performed in the biological safety cabinet of BSL3.

Statistical analysis

Listen (opens in a new tab)

Statistical analyses were performed with GraphPad Prism 8.2 (GraphPad Software, La Jolla, CA). Statistical significance was analyzed using one-way analysis of variance (ANOVA) with the Bonferroni post hoc test. Differences were considered statistically significant at P < 0.05.

Ethical approval statement

Listen (opens in a new tab)

All infectious experiments were reviewed and approved by the Biosafety Committee of Kitasato University (approval numbers: A06-116 and 199) and the Kitasato University Medical Ethics Organization (approval number: COVID-19-CT001).

RESULTS

Evaluation of HOCl virucidal efficacy against SARS-CoV-2 by suspension test

Listen (opens in a new tab)

Virucidal efficacies of HOCl against SARS-CoV-2 are shown in Figure 1. Virus stocks containing 2% FBS were mixed with 10, 30, 50, 100, and 200 ppm HOCl solution for 20 s and 5 min at room temperature at a ratio of 1: 9. In the presence of 0.2% FBS, the HOCl solution with the concentration not less than 30 ppm was significantly effective against the Pango lineage A virus strain (JPN/TY/WK-521), resulting in a 5.2–5.4 log10 decrease. In contrast, the 10 ppm HOCl solution had no anti-SARS-CoV-2 effect (Figure 1(a)). Using the Pango lineage B.1.617.2 virus strain (KUH355), the HOCl solution with the concentration not less than 30 ppm was significantly effective against SARS-CoV-2, resulting in a 1.3–5.8 log10 decrease. In contrast, the HOCl solution at 10 ppm did not exert any SARS-CoV-2 virucidal efficacy (Figure 1(b)). The cytopathic effects of 200 ppm HOCl and Na2S2O3 stop solution on VeroE6/TMPRSS2 cells were not observed (Supplementary Figure 1).

Figure 1

Evaluation of HOCl virucidal efficacy against SARS-CoV-2. SARS-CoV-2 virus solution was treated with various concentrations of ionless hypochlorous acid water, as described in Materials and Methods. (a) Pango lineage A virus (JPN/TY/WK-521) strain treated with 10 (white bar), 30 (light gray bar), 50 (gray bar), 100 (dark gray bar), and 200 (black dot bar) ppm of HOCl solution. (b) Pango lineage B.1.617.2 virus (KUH355) strain treated with 10 (white bar), 30 (light gray bar), 50 (gray bar), 100 (dark gray bar), and 200 (black dot bar) ppm of HOCl solution. The ddw (black bar) indicates that the virus solution was treated with water for injection. Na2S2O3 (gray dot bar) indicates that 200 ppm HOCl solution pretreated with 10% Na2S2O3 solution was mixed with the SARS-CoV-2 virus solution. Data were analyzed using one-way ANOVA with the Bonferroni post hoc test. **** p < 0.0001.

View large (opens in a new tab)Download slide (opens in a new tab)

Evaluation of HOCl virucidal efficacy against SARS-CoV-2. SARS-CoV-2 virus solution was treated with various concentrations of ionless hypochlorous acid water, as described in Materials and Methods. (a) Pango lineage A virus (JPN/TY/WK-521) strain treated with 10 (white bar), 30 (light gray bar), 50 (gray bar), 100 (dark gray bar), and 200 (black dot bar) ppm of HOCl solution. (b) Pango lineage B.1.617.2 virus (KUH355) strain treated with 10 (white bar), 30 (light gray bar), 50 (gray bar), 100 (dark gray bar), and 200 (black dot bar) ppm of HOCl solution. The ddw (black bar) indicates that the virus solution was treated with water for injection. Na2S2O3 (gray dot bar) indicates that 200 ppm HOCl solution pretreated with 10% Na2S2O3 solution was mixed with the SARS-CoV-2 virus solution. Data were analyzed using one-way ANOVA with the Bonferroni post hoc test. **** p < 0.0001.

Virucidal efficacies of HOCl against SARS-CoV-2 in the presence of 0.02% FBS are shown in Figure 2. In the presence of a 0.02% FBS, the HOCl solution with concentration not less than 10 ppm was significantly effective against both the JPN/TY/WK-521 and KUH355 strains of SARS-CoV-2, resulting in a 5.3 and 6.7 log10 decrease, respectively. In contrast, 1 ppm HOCl solution had no virucidal effect on SARS-CoV-2 (Figure 2). The virucidal efficacy of HOCl in the presence of 0.02% FBS was 10 times greater than that in the presence of 0.2% FBS; 200 ppm HOCl pretreated with 10% Na2S2O3 did not observe the virucidal efficacy against SARS-CoV-2 in the presence of 0.2 and 0.02% FBS (Figures 1 and 2).

Figure 2

Influence of organic compounds on the SARS-CoV-2 virucidal efficacy of HOCl. SARS-CoV-2 virus solution was treated with various concentration of ionless hypochlorous acid water, as described in Materials and Methods. (a) JPN/TY/WK-521 strain treated with 1 (white bar), 30 (light gray bar), 50 (gray bar), and 100 (dark gray bar) ppm of HOCl solution. (b) KUH355 strain treated with 1 (white bar), 30 (light gray bar), 50 (gray bar), and 100 (dark gray bar) ppm of HOCl solution. The ddw (black bar) indicates that the viral solution was treated with water for injection. Na2S2O3 (gray dot bar) indicates that 200 ppm HOCl solution pretreated by 10% Na2S2O3 solution was pretreated with SARS-CoV-2 virus solution. Data were analyzed using one-way ANOVA with the Bonferroni post hoc test. **** p < 0.0001.

View large (opens in a new tab)Download slide (opens in a new tab)

Influence of organic compounds on the SARS-CoV-2 virucidal efficacy of HOCl. SARS-CoV-2 virus solution was treated with various concentration of ionless hypochlorous acid water, as described in Materials and Methods. (a) JPN/TY/WK-521 strain treated with 1 (white bar), 30 (light gray bar), 50 (gray bar), and 100 (dark gray bar) ppm of HOCl solution. (b) KUH355 strain treated with 1 (white bar), 30 (light gray bar), 50 (gray bar), and 100 (dark gray bar) ppm of HOCl solution. The ddw (black bar) indicates that the viral solution was treated with water for injection. Na2S2O3 (gray dot bar) indicates that 200 ppm HOCl solution pretreated by 10% Na2S2O3 solution was pretreated with SARS-CoV-2 virus solution. Data were analyzed using one-way ANOVA with the Bonferroni post hoc test. **** p < 0.0001.

Evaluation of virucidal efficacy of HOCl atomization against SARS-CoV-2

Listen (opens in a new tab)

Although the virucidal efficacy of HOCl was dependent on the presence of organic compounds, the suspension test indicated sufficient SARS-CoV-2 virucidal efficacy. To investigate the SARS-CoV-2 virucidal efficacy of atomized HOCl, we conducted the spray test in the test chamber (Figure 3). When sprayed with 500 ppm HOCl, no clear change was observed in the virus titer of the KUH355 strain solution containing 0.2% FBS after spraying for 1 h, but it was significantly suppressed after spraying for 3 and 5 h, by 2.3 log10 and 5.7 log10, respectively (Figure 4(a)). Next, the KUH355 strain solution containing 0.02% FBS was atomized by 10, 30, and 300 ppm HOCl solution for 1, 3, and 5 h. When sprayed with 300 ppm HOCl, the virus titer of KUH355 strain solution containing 0.02% FBS was significantly suppressed after spraying for 1, 3, and 5 h, by 5.1 log10, 4.2 log10, and 4.1 log10, respectively (Figure 4(b)). In the presence of 0.02% FBS, the atomized HOCl solution at 30 ppm was significantly effective for 3 and 5 h, resulting in a 2.8 and 4.1 log10 decrease, respectively (Figure 4(b)), suggesting that HOCl atomization showed dose- and time-dependent effectiveness despite the presence of organic compounds. The virus titer of the control group showed a gradual decrease in a time-dependent manner for KUH355 strain (Figure 4(a) and 4(b)). We also continuously monitored the change in relative humidity and atmospheric available chlorine concentration (ACC) in the test chamber. When 10, 30, 300, and 500 ppm HOCl was atomized in the same way as for the spray test, ACC remained constant as relative humidity of about 90% was maintained in the chamber during the test. ACC at 5 h after spraying with 10, 30, 300, and 500 ppm HOCl showed 0.01 ± 0.008, 0.051 ± 0.012, 0.175 ± 0.050, and 0.311 ± 0.029 ppm, respectively (Supplementary Figure 2).

Figure 3

Diagrammatic representation of the chamber. (a) Schema of the chamber used for the spray test. (b) Photo graph of the chamber.

View large (opens in a new tab)Download slide (opens in a new tab)

Diagrammatic representation of the chamber. (a) Schema of the chamber used for the spray test. (b) Photo graph of the chamber.

Figure 4

Evaluation of SARS-CoV-2 virucidal efficacy of atomized HOCl. SARS-CoV-2 virus solution was treated with various concentrations of ionless hypochlorous acid water, as described in Materials and Methods. (a) KUH355 virus strain in the presence of 0.2% FBS condition atomized with 30 (gray bar), 300 (dark gray bar), and 500 (dot bar) ppm of HOCl solution. (b) KUH355 strain in the presence of 0.02% FBS condition atomized with 10 (gray bar), 30 (dark gray bar), and 300 (dot bar) ppm of HOCl solution. The control (white bar) indicates the sequential reduction of the viral titer during the spray test. The stock (black bar) indicates the viral titer of a virus stock solution. The ddw (light gray bar) indicates that the virus solution was atomized with double distilled water. Data were analyzed using one-way ANOVA with the Bonferroni post hoc test. * p < 0.05. ** p < 0.005. **** p < 0.0001.

View large (opens in a new tab)Download slide (opens in a new tab)

Evaluation of SARS-CoV-2 virucidal efficacy of atomized HOCl. SARS-CoV-2 virus solution was treated with various concentrations of ionless hypochlorous acid water, as described in Materials and Methods. (a) KUH355 virus strain in the presence of 0.2% FBS condition atomized with 30 (gray bar), 300 (dark gray bar), and 500 (dot bar) ppm of HOCl solution. (b) KUH355 strain in the presence of 0.02% FBS condition atomized with 10 (gray bar), 30 (dark gray bar), and 300 (dot bar) ppm of HOCl solution. The control (white bar) indicates the sequential reduction of the viral titer during the spray test. The stock (black bar) indicates the viral titer of a virus stock solution. The ddw (light gray bar) indicates that the virus solution was atomized with double distilled water. Data were analyzed using one-way ANOVA with the Bonferroni post hoc test. * p < 0.05. ** p < 0.005. **** p < 0.0001.

DISCUSSION

Listen (opens in a new tab)

This study was performed to determine whether HOCl, produced by electrolysis of saturated chloride solution and filtrated through a reverse osmosis membrane to remove ions, had antiseptic efficacy against SARS-CoV-2 infectivity in the presence of organic compounds and under conditions of atomization. In the suspension test, we demonstrated a reduction of SARS-CoV-2 infectivity by contact with the HOCl solution for 20 s and 5 min. We found that the presence of organic compounds affected SARS-CoV-2 infectivity depending on the level of the ACC in the HOCl solution. We also observed that HOCl atomization significantly reduced SARS-CoV-2 infectivity in the spray test. The presence of organic compounds, including FBS, greatly affected the virucidal efficacy against SARS-CoV-2 in the suspension test and atomization test.

HOCl, a reactive chlorine species similar to ClO− and Cl2, is a high-potency oxidizing agent (Deborde & von Gunten 2008). In the innate immune system, HOCl is generated from hydrogen peroxide and chloride ions by myeloperoxidase (MPO) in phagocytes (Pattison et al. 2012; Winterbourn & Kettle 2013). Then, neutrophils and monocytes utilize HOCl to eliminate invading microorganisms (Gray et al. 2013; Da Cruz Nizer et al. 2020). MPO-knockout mice physiologically demonstrate increased susceptibility to infection with Candida albicans and Klebsiella pneumoniae in comparison with wild-type mice (Hirche et al. 2005; Homme et al. 2013). The HOCl solution shows powerful antibacterial efficacy against Gram-positive bacteria (Bacillus spp., Clostridium spp., Staphylococcus spp., Streptococcus spp.) and Gram-negative bacteria (Bordetella spp., Campylobacter spp., Vibrio spp., Pseudomonas spp.); Actinomycetaceae (Corynebacterium spp.); and Enterobacteriaceae (Escherichia spp., Shigella spp., Yersinia spp.), as well as virucidal efficacy against DNA (Adenoviridae, Herpesviridae) and RNA (Orthomyxoviridae, Coronaviridae) viruses (Tachikawa et al. 1999; Tagawa et al. 2000; Huang et al. 2008; Taharaguchi et al. 2014; Tamaki et al. 2014; Takeda et al. 2020; Miyaoka et al. 2021).

Previous studies using the suspension test have reported that treatment with HOCl solution can inactivate SARS-CoV-2 in cultured cells, such as VeroE6/TMPRSS2 cells. Hatanaka et al. (2022) have reported that 28.1 ppm HOCl solution achieved a 4-log reduction of SARS-CoV-2 infectivity within 10 s. In addition, 29.7 and 59.4 ppm HOCl solution achieved a 3.7–3.9- and 5-log reduction of SARS-CoV-2 infectivity within 10 s to 3 min in the presence of 0.1% FBS. Takeda et al. (2021) have reported that a residual chlorine concentration of 51–56 ppm in HOCl solution achieved >4-log reduction of SARS-CoV-2 infectivity within 20 s in the presence of 0.05% FBS. NITE summarized the results of the virucidal efficacy against SARS-CoV-2 at five facilities. They showed that a 19–200 ppm HOCl solution achieved a 3- and 4-log reduction of SARS-CoV-2 infectivity within 20 s to 5 min in the presence of 0.05–0.25% FBS. These studies have reported that viral solutions were prepared in the viral growth medium containing 1–5% FBS. The reaction rates of the virus solution and HOCl were 1:9 or 1:19. Then, they evaluated virucidal efficacy at a final concentration of 0.05–0.25% FBS. Moreover, previous studies have reported that the amount of protein in saliva, which is the cause of the droplet infection, is usually 100 times lower than that in plasma. Saliva contains 2% of proteins and 98% of water (Nunes et al. 2011; Kang & Kho 2018). Therefore, we chose the concentration of 0.2% and 0.02% FBS. In the present study, we found that 30 ppm HOCl solution achieved >5-log reduction of JPN/TY/WK-521 strain infectivity within 20 s in the presence of 0.2% FBS. In contrast, we demonstrated that 30 ppm HOCl solution achieved a 1.1-log reduction in KUH355 strain infectivity within 20 s in the presence of 0.2% FBS. This difference in the virucidal efficacy might affect the Delta variant, which is more transmissible than the original variant (Mistry et al. 2022). We also indicated that 10 ppm HOCl solution achieved sufficient reduction (>5 log) of JPN/TY/WK-521 and KUH355 virus strains infectivity within 20 s in the presence of 0.02% FBS. Thus, 30 ppm HOCl solution for 20 s may be sufficient to prevent the infection of the original SARS-CoV-2 strain. In contrast, the more transmissible mutant SARS-CoV-2 strain may require 50 ppm HOCl solution for > 20 s.

To reduce the risk of airborne transmission of pathogens, the bactericidal and virucidal efficacies of HOCl solution have been previously evaluated using atomization. Hakim et al. (2016) have reported that 50 and 100 ppm HOCl solution achieved an approximately 4-log reduction of Escherichia coli and Salmonella infantis in dry conditions within 5 min of atomization. Benedusi et al. (2022) have also reported that 300 ppm HOCl solution showed 69–99.9% reduction of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa with 10 min of atomization, although bactericidal activities were affected by the differences in material surfaces, such as semi-porous, flat, and porous. They also showed that 300 ppm HOCl solution achieved >95% reduction of human coronavirus 229E and adenovirus with 5–10 min of atomization. Urushidani et al. (2022) intermittently sprayed 250 or 8,700 ppm HOCl solutions for 2.5–5 s (each 4 min) in the test chamber and reported that 250 ppm HOCl solution did not neutralize air-dried SARS-CoV-2 infectivity after 16 min HOCl exposure. However, 8,700 ppm HOCl solution reduced air-dried SARS-CoV-2 infectivity to decrease the limit of detection within 12 min for 16 min HOCl exposure. In the present study, we found that atomized HOCl at 300 and 500 ppm for 3 and 5 h achieved a 1.4–2.3 and 2.3–5.7 log reduction of KUH355 virus solution infectivity in the presence of 0.2% FBS. We also observed that 30 ppm HOCl atomization for 3 and 5 h achieved 2.8–4.1 log reduction of KUH355 viral solution infectivity in the presence of 0.02% FBS. Moreover, SARS-CoV-2 infectivity in the presence of 0.02% FBS was reduced by >4-log by 300 ppm of HOCl atomization for 1, 3, and 5 h. Our results suggest that the HOCl solution may have effective virucidal efficacy against SARS-CoV-2, although a longer atomization time compared with a previous report may be needed. Our data also showed that atmospheric ACC is constantly maintained at <0.40 ppm in 200-L test chamber after atomization with 500 ppm HOCl. Our test chamber was almost twofold in volume as that reported in another study, in which the chlorine concentration was approximately 10 ppm with 8,700 ppm atomization. Therefore, differences in chlorine concentration in the experimental chamber may have influenced the virucidal efficacies against SARS-CoV-2 we observed in this study.

The WHO does not recommend the disinfection of COVID-19 by fogging environmental surfaces with disinfectant, as it may increase the risk of adverse effects to the eyes, respiratory tract, and skin. Because HOCl reportedly did not cause these adverse effects, the adverse effects of HOCl are probably related to the chlorine concentration and pH of the exposed HOCl. In addition, no adverse events were observed by drinking 20–60 ppm HOCl water in animal studies, washing wounds with 200 ppm HOCl solution, and mouth washing with 80 and 200 ppm HOCl solution in clinical studies (Morita et al. 2011; Kubota et al. 2015; Block & Rowan 2020; Alzahrani et al. 2022; Sevinç Güll et al. 2022). Although the effect of the high purity of HOCl on adverse events is unclear, HOCl should be atomized under controlled conditions at the appropriate concentration. Our results, which prove the relationship between the virucidal efficacy and the ACC of HOCl, suggest that HOCl atomization for disinfection may be useful for cleaning unmanned hospital rooms, schools, daycare centers, and various facilities at night.

CONCLUSIONS

Listen (opens in a new tab)

We have clarified that both aqueous and atomized HOCl solutions are effective in neutralizing SARS-CoV-2 infectivity. The virucidal efficacy of HOCl was not influenced by the difference in SARS-CoV-2 variants (Pango lineage A and B virus strains). In addition, we showed the virucidal efficacy of HOCl atomization against SARS-CoV-2. HOCl atomization may reduce the burden of cleaning and disinfection work in various facilities such as hospital rooms, daycare centers, and schools.

ACKNOWLEDGEMENTS

Listen (opens in a new tab)

The authors thank laboratory staffs of Kitasato University and NIPRO Corporation for technical and experimental supports.

FUNDING

Listen (opens in a new tab)

This study was supported by the COVID-19 Kitasato Project Study and Research on Emerging and Re-emerging Infectious Diseases and Immunization on Health, Labour and Welfare Policy Research Grants (grant number 21HA2017). This study was funded by a research grant from NIPRO Corporation.

FINANCIAL INTERESTS

Listen (opens in a new tab)

Author M.K. received research support from NIPRO Corporation. All authors except M.K. have no financial interests.

CONTRIBUTIONS

Listen (opens in a new tab)

M.K., R.E., H.F., N.S., and N.K. performed the study concept and design. M.K. and R.E. performed writing the original draft. M.K., R.E., S.M., H.F., N.S., N.K., H.K., and H.H. performed the development of methodology and writing, review, and revision of the manuscript. M.K., R.E., H.F., and N.S. provided acquisition, analysis and interpretation of data, and statistical analysis. H.F., N.S., and N.K. provided reagents, materials, test chamber, and instrumentations. N.K., H.K., and H.H. supervised and provided the financial support for this project. All authors have read and approved the final manuscript.

DATA AVAILABILITY STATEMENT

Listen (opens in a new tab)

All relevant data are included in the paper or its Supplementary Information.

CONFLICT OF INTEREST STATEMENT

Listen (opens in a new tab)

M.K. received research support from NIPRO Corporation. All authors except M.K. have no financial interests.

REFERENCES

Alzahrani

M. M.

,

Bamashmous

S.

,

Alkharobi

H.

,

Alghamdi

A.

,

Alharbi

R. H.

,

Hassan

A. M.

,

Darwish

M.

,

Bukhari

A.

,

Mahmoud

A. B.

,

Alfaleh

M. A.

,

Mirza

A. A.

,

Abuzenadah

A. M.

,

Abujamel

T. S.

&

Hashem

A. M.

2022

Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial

.

Journal of Medical Virology

95,

e28412

.

Google Scholar (opens in a new tab)

Aratani

Y.

2018

Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function (opens in a new tab)

.

Archives of Biochemistry and Biophysics

640

,

47

–

52

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Behrens

H.

&

Karber

S.

1953

Determination of LD50

.

Archiv fur Experimentelle Pathologie und Pharmakologie

2

,

177

–

372

.

Google Scholar (opens in a new tab)

Benedusi

M.

,

Tamburini

E.

,

Sicurella

M.

,

Summa

D.

,

Ferrara

F.

,

Marconi

P.

,

Cervellati

F.

,

Costa

S.

&

Valacchi

G.

2022

The lesson learned from the COVID-19 pandemic: Can an active chemical be effective, safe, harmless-for-humans and low-cost at a time? Evidence on aerosolized hypochlorous acid (opens in a new tab)

.

International Journal of Environmental Research and Public Health

19

,

13163

.

doi: 10.3390/ijerph192013163

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Block

M. S.

&

Rowan

B. G.

2020

Hypochlorous acid: A review (opens in a new tab)

.

Journal of Oral and Maxillofacial Surgery

78

,

1461

–

1466

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Chen

N.

,

Zhou

M.

,

Dong

X.

,

Qu

J.

,

Gong

F.

,

Han

Y.

,

Qiu

Y.

,

Wang

J.

,

Liu

Y.

,

Wei

Y.

,

Xia

J.

,

Yu

T.

,

Zhang

X.

&

Zhang

L.

2020

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study (opens in a new tab)

.

Lancet

395

,

507

–

513

.

doi: 10.1016/S0140-6736(20)30211-7

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

da Cruz Nizer

W. S.

,

Inkovskiy

V.

&

Overhage

J.

2020

Surviving reactive chlorine stress: Responses of gram-negative bacteria to hypochlorous acid (opens in a new tab)

.

Microorganisms

8

,

1220

.

doi: 10.3390/microorganisms8081220

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Deborde

M.

&

von Gunten

U.

2008

Reactions of chlorine with inorganic and organic compounds during water treatment-kinetics and mechanisms: A critical review (opens in a new tab)

.

Water Research

42

,

13

–

51

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Falk

N. A.

2019

Surfactants as antimicrobials: A brief overview of microbial interfacial chemistry and surfactant antimicrobial activity (opens in a new tab)

.

Journal of Surfactants and Detergents

22

,

1119

–

1127

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Gerba

C. P.

2015

Quaternary ammonium biocides: Efficacy in application (opens in a new tab)

.

Applied and Environmental Microbiology

81

,

464

–

469

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Gray

M. J.

,

Wholey

W. Y.

&

Jakob

U.

2013

Bacterial response to reactive chlorine species (opens in a new tab)

.

Annual Review of Microbiology

67

,

141

–

160

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Guan

W. J.

,

Ni

Z. Y.

,

Hu

Y.

,

Liang

W. H.

,

Ou

C. Q.

,

He

J. X.

,

Liu

L.

,

Shan

H.

,

Lei

C. L.

,

Hui

D. S. C.

,

Du

B.

,

Li

L. J.

,

Zeng

G.

,

Yuen

K. Y.

,

Chen

R. C.

,

Tang

C. L.

,

Wang

T.

,

Chen

P. Y.

,

Xiang

J.

,

Li

S. Y.

,

Wang

J. L.

,

Liang

Z. J.

,

Peng

Y. X.

,

Wei

L.

,

Liu

Y.

,

Hu

Y. H.

,

Peng

P.

,

Wang

J. L.

,

Liu

J. Y.

,

Chen

Z.

,

Li

G.

,

Zheng

Z. J.

,

Qiu

S. Q.

,

Luo

J.

,

Ye

C. J.

,

Zhu

S. Y.

&

Zhong

N. S.

&

China Medical Treatment Expert Group for Covid-19

2020

Clinical characteristics of coronavirus disease 2019 in China (opens in a new tab)

.

New England Journal of Medicine

382

,

1708

–

1720

.

doi: 10.1056/NEJMoa2002032

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Hakim

H.

,

Alam

S.

,

Sangsriratanakul

N.

,

Nakajima

K.

,

Kitazawa

M.

,

Ota

M.

,

Toyofuku

C.

,

Yamada

M.

,

Thammakarn

C.

,

Shoham

D.

&

Takehara

K.

2016

Inactivation of bacteria on surfaces by sprayed slightly acidic hypochlorous acid water: (opens in a new tab)In vitro (opens in a new tab) experiments (opens in a new tab)

.

The Journal of Veterinary Medical Science

78

,

1123

–

1128

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Hakim, H., Thammakarn C., Suguro A., Ishida Y., Kawamura A., Tamura M., Satoh K., Tsujimura M., Hasegawa T. & Takehara K. 2015 Evaluation of sprayed hypochlorous acid solutions for their virucidal activity against avian influenza virus through in vitro experiments (opens in a new tab). The Journal of Veterinary Medical Science 77, 211–215.

Hatanaka

N.

,

Yasugi

M.

,

Sato

T.

,

Mukamoto

M.

&

Yamasaki

S.

2022

Hypochlorous acid solution is a potent antiviral agent against SARS-CoV-2 (opens in a new tab)

.

Journal of Applied Microbiology

132

,

1496

–

1502

.

doi: 10.1111/jam.15284

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Hawkins

C. L.

&

Davies

M. J.

2002

Hypochlorous-induced damage to DNA, RNA, and polynucleotides: Formation of chloramines and nitrogen-centered radicals (opens in a new tab)

.

Chemical Research in Toxicology

15

,

83

–

92

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Hawkins

C. L.

&

Davies

M. J.

2021

Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage (opens in a new tab)

.

Free Radical Biology and Medicine

172

,

633

–

651

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Hirche

T. O.

,

Gaut

J. P.

,

Heinecke

J. W.

&

Belaaouaj

A.

2005

Myeloperoxidase plays critical roles in killing (opens in a new tab)Klebsiella pneumoniae (opens in a new tab) and inactivating neutrophil elastase: Effects on host defense (opens in a new tab)

.

Journal of Immunology

174

,

1557

–

1565

.

doi: 10.4049/jimmunol.174.3.1557

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

Hirose

R.

,

Ikegaya

H.

,

Naito

Y.

,

Watanabe

N.

,

Yoshida

T.

,

Bandou

R.

,

Daidoji

T.

,

Itoh

Y.

&

Nakaya

T.

2021

Survival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus on human skin: Importance of hand hygiene in coronavirus disease 2019 (COVID-19) (opens in a new tab)

.

Clinical Infectious Diseases

73

,

e4329

–

e4335

.

doi: 10.1093/cid/ciaa1517

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Homme

M.

,

Tateno

N.

,

Miura

N.

,

Ohno

N.

&

Aratani

Y.

2013

Myeloperoxidase deficiency in mice exacerbates lung inflammation induced by nonviable (opens in a new tab)Candida albicans (opens in a new tab)

.

Inflammation Research

62

,

981

–

990

.

doi: 10.1007/s00011-013-0656-6

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Hu

B.

,

Guo

H.

,

Zhou

P.

&

Shi

Z. L.

2021

Characteristics of SARS-CoV-2 and COVID-19 (opens in a new tab)

.

Nature Reviews Microbiology

19

,

141

–

154

.

doi: 10.1038/s41579-020-00459-7

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Huang

A. R.

,

Hung

Y. C.

,

Hsu

S. Y.

,

Huang

Y. W.

&

Hwang

D. T.

2008

Application of electrolyzed water in the food industry (opens in a new tab)

.

Food Control

19

,

329

–

345

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

Kang

J. H.

&

Kho

H. S.

2018

Blood contamination in salivary diagnostics: Current methods and their limitations (opens in a new tab)

.

Clinical Chemistry and Laboratory Medicine

57

,

1115

–

1124

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

Kubota

A.

,

Goda

T.

,

Tsuru

T.

,

Yonekura

T.

,

Yagi

M.

,

Kawahara

H.

,

Yoneda

A.

,

Tazuke

Y.

,

Tani

G.

,

Ishii

T.

,

Umeda

S.

&

Hirano

K.

2015

Efficacy and safety of strong acid electrolyzed water for peritoneal lavage to prevent surgical site infection in patients with perforated appendicitis (opens in a new tab)

.

Surg Today

45

,

876

–

879

.

doi: 10.1007//s00595-014-1050x

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Leung

N. H. L.

2021

Transmissibility and transmission of respiratory viruses (opens in a new tab)

.

Nature Reviews Microbiology

19

,

528

–

545

.

doi: 10.1038/s41579-021-00535-6

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

McDonnell

G.

&

Russell

A. D.

1999

Antiseptics and disinfectants: Activity, action, and resistance (opens in a new tab)

.

Clinical Microbiology Reviews

12

,

147

–

179

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Mistry

P.

,

Barmania

F.

,

Mellet

J.

,

Peta

K.

,

Strydom

A.

,

Viljoen

I. M.

,

James

W.

,

Gordon

S.

&

Pepper

M. S.

2022

SARS-CoV-2 variants, vaccines, and host immunity (opens in a new tab)

.

Frontiers in Immunology

12

,

809244

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Miyaoka

Y.

,

Kabir

H.

,

Hasan

A.

,

Yamaguchi

M.

,

Shoham

D.

,

Murakami

H.

&

Takehara

K.

2021

Virucidal activity of slightly acidic hypochlorous acid water toward influenza virus and coronavirus with tests simulating practical usage (opens in a new tab)

.

Virus Research

297

,

198383

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Miyazaki

N.

,

Sakata

M.

,

Kurumiya

A.

,

Nakamura

A.

,

Ohta

H.

,

Hirai

J.

,

Mori

N.

&

Mikamo

H.

2022

Verification for the efficacy of atomizing of hypochlorous acid water to Clostridiodes difficile in the hospital room

.

Journal of the Association for Anaerobic Infection Research

52

,

78

–

89

.

Google Scholar (opens in a new tab)

Morita

C.

,

Nishida

T.

&

Ito

K.

2011

Biological toxicity of acid electrolyzed functional water: Effect of oral administration on mouse digestive tract and changes in body weight (opens in a new tab)

.

Archives of Oral Biology

56

,

359

–

366

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

NITE

2022

Final Report on Efficacy Assessment of Disinfecting Substances Alternative to Alcohol for Use Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

.

Available from: https://www.nite.go.jp/data/000115863.pdf (opens in a new tab).

Nunes

L. A. S.

,

Brenzikofer

R.

&

Macedo

D. V.

2011

Reference intervals for saliva analytes collected by a standardized method in a physically active population (opens in a new tab)

.

Clinical Biochemistry

44

,

1440

–

1444

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Park

G. W.

,

Boston

D. M.

,

Kase

J. A.

,

Sampson

M. N.

&

Sobsey

M. D.

2007

Evaluation of liquid- and fog-based application of Sterilox hypochlorous acid solution for surface inactivation of human norovirus (opens in a new tab)

.

Applied and Environmental Microbiology

73

,

4463

–

4468

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Pattison

D. I.

,

Davies

M. J.

&

Hawkins

C. L.

2012

Reactions and reactivity of myeloperoxidase-derived oxidants: Differential biological effects of hypochlorous and hypothiocyanous acids (opens in a new tab)

.

Free Radical Research

46

,

975

–

995

.

doi: 10.3109/10715762.2012.667566

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Qiao

Z.

,

Ye

Y.

,

Szczuka

A.

,

Harrison

K. R.

,

Dodd

M. C.

&

Wigginton

K. R.

2022

Reactivity of viral nucleic acids with chlorine and the impact of virus encapsidation (opens in a new tab)

.

Environmental Science & Technology

56

,

218

–

227

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

Riddell

S.

,

Goldie

S.

,

Hill

A.

,

Eagles

D.

&

Drew

T. W.

2020

The effect of temperature on persistence of SARS-CoV-2 on common surfaces (opens in a new tab)

.

Virology Journal

17

,

145

.

doi: 10.1186/s12985-020-01418-7

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Sevinç Güll

S. N.

,

Dilsiz

A.

,

Saglik

I.

&

Aidin

N. N.

2022

Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial (opens in a new tab)

.

Dental and Medical Problems

59

,

357

–

363

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Spickett

C. M.

,

Jerlich

A.

,

Panasenko

O. M.

,

Arnhold

J.

,

Pitt

A. R.

,

Stelmaszynska

T.

&

Schaur

R. J.

2000

The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids (opens in a new tab)

.

Acta Biochimica Polonica

47

,

889

–

899

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Tachikawa

T.

,

Watari

E.

,

Someya

K.

,

Ikeda

T.

,

Araake

M.

,

Fujimaki

W.

,

Kanai

T.

,

Uchiyama

T.

&

Miyanaga

Y.

1999

Efficacy of weak acid electrolytic water against various kinds of pathogenic microorganisms

.

Japanese Journal of Infection Prevention and Control

14

,

255

–

263

.

Google Scholar (opens in a new tab)

Tagawa

M.

,

Yamaguchi

T.

,

Yokosuka

O.

,

Matsutani

S.

,

Maeda

T.

&

Saisho

H.

2000

Inactivation of hepadnavirus by electrolyzed acid water (opens in a new tab)

.

Journal of Antimicrobial Chemotherapy

46

,

363

–

368

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Taharaguchi

M.

,

Takimoto

K.

,

Zamamoto-Niikura

A.

&

Yamada

Y. K.

2014

Effect of weak acid hypochlorous solution on selected viruses and bacteria of laboratory rodents (opens in a new tab)

.

Experimental Animals

63

,

141

–

147

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Takeda

Y.

,

Uchimi

H.

,

Matsuda

S.

&

Ogawa

H.

2020

Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus (opens in a new tab)

.

Biochemical and Biophysical Research Communications

530

,

1

–

3

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Takeda

Y.

,

Matsuda

S.

,

Jamsransren

D.

&

Ogawa

H.

2021

Comparison of the SARS-CoV-2-inactivating activities of the differently manufactured hypochlorous acid water products with various pH (opens in a new tab)

.

Journal of Water and Health

19

,

448

–

456

.

doi: 10.2166/wh.2021.260

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Tamaki

S.

,

Bui

V. N.

,

Ngo

L. H.

,

Ogawa

H.

&

Imai

K.

2014

Virucidal effect of acidic electrolyzed water and neutral electrolyzed water on avian influenza viruses (opens in a new tab)

.

Archives of Virology

159

,

405

–

412

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Tischer

M.

,

Pradel

G.

,

Ohlsen

K.

&

Holzgrabe

U.

2012

Quaternary ammonium salts and their antimicrobial potential: Targets or nonspecific interactions? (opens in a new tab)

ChemMedChem

7

,

22

–

31

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Tsujimura

K.

,

Murase

H.

,

Bannai

H.

,

Nemoto

M.

,

Yamanaka

T.

&

Kondo

T.

2015

Efficacy of five commercial disinfectants and one anionic surfactant against equine herpesvirus type 1 (opens in a new tab)

.

The Journal of Veterinary Medical Science

77

,

1545

–

1548

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Urushidani

M.

,

Kawayoshi

A.

,

Kotaki

T.

,

Saeki

K.

,

Mori

Y.

&

Kameoka

M.

2022

Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxidase solution (opens in a new tab)

.

PLOS One

17

,

e0261802

.

doi: 10.1371/journal.pone.0261802

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

van Doremalen

N.

,

Bushmaker

T.

,

Morris

D. H.

,

Holbrook

M. G.

,

Gamble

A.

,

Williamson

B. N.

,

Tamin

A.

,

Harcourt

J. L.

,

Thornburg

N. J.

,

Gerber

S. I.

,

Lloyd-Smith

J. O.

,

de Wit

E.

&

Munster

V. J.

2020

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 (opens in a new tab)

.

New England Journal of Medicine

382

,

1564

–

1567

.

doi: 10.1056/NEJMc20004973

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Wang

L.

,

Bassiri

M.

,

Najafi

R.

,

Yang

J.

,

Khosrovi

B.

,

Hwong

W.

,

Barati

E.

,

Belisle

B.

,

Celeri

C.

&

Robson

M. C.

2007

Hypochlorous acid as a potential wound care agent

.

Journal of Burns and Wounds

6

,

65

–

79

.

Google Scholar (opens in a new tab)

Wiktorczyk-Kapischke

N.

,

Grudlewska-Buda

K.

,

Walecka-Zacharska

E.

,

Kwiecinska-Pirog

J.

,

Radtke

L.

,

Gospodarek-Komkowska

E.

&

Skowron

K.

2021

SARS-CoV-2 in the environment non-droplet spreading routes (opens in a new tab)

.

Science of the Total Environment

770

,

145260

.

doi: 10.1016/j.scitotenv.2021.145260

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Winterbourn

C. C.

&

Kettle

A. J.

2013

Redox reactions and microbial killing in the neutrophil phagosome (opens in a new tab)

.

Antioxidants & Redox Signaling

18

,

642

–

660

.

doi: 10.1089/ars.2012.4827

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

World Health Organization

2021

Hypochlorous Acid (HOCl) for Disinfection, Antisepsis, and Wound Care in Core Categories 15.1, 15.2, and 13

.

Available from: https://cdn.who.int>default-source>expert-reviews (opens in a new tab)

World Health Organization

2023

Weekly epidemiological update on COVID-19-1 September 2023. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (opens in a new tab)

Xiao

S.

,

Yuan

Z.

&

Huang

Y.

2022

Disinfectants against SARS-CoV-2: A review (opens in a new tab)

.

Viruses

14

,

1721

.

doi: 10.3390/v14081721

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

Zhu

N.

,

Zhang

D.

,

Wang

W.

,

Li

X.

,

Yang

B.

,

Song

J.

,

Zhao

X.

,

Huang

B.

,

Shi

W.

,

Lu

R.

,

Niu

P.

,

Zhan

F.

,

Ma

X.

,

Wang

D.

,

Xu

W.

,

Wu

G.

,

Gao

G. F.

&

Tan

W.

&

China Novel Coronavirus Investigating and Research Team

2020

A novel coronavirus from patients with pneumonia in China, 2019 (opens in a new tab)

.

New England Journal of Medicine

382

,

727

–

733

.

doi: 10.1056/NEJMoa2001017

.

Google Scholar (opens in a new tab)

Crossref (opens in a new tab)

PubMed (opens in a new tab)

© 2024 The Authors

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC BY 4.0), which permits copying, adaptation and redistribution, provided the original work is properly cited (http://creativecommons.org/licenses/by/4.0/ (opens in a new tab)).